Skip to content

A Randomized Controlled Trial for Transcranial Direct Current Stimulation in the Treatment of Generalized Anxiety Disorder

A Randomized Controlled Trial for Transcranial Direct Current Stimulation in the Treatment of Generalized Anxiety Disorder

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800018094
Enrollment
Unknown
Registered
2018-08-29
Start date
2018-08-30
Completion date
Unknown
Last updated
2018-09-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

generalized anxiety disorder

Interventions

Group 1:tDCS
Group 2:sham tDCS

Sponsors

Xuanwu Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Age 18-65 years, right-handed; 2. Diagnosed as generalized anxiety disorder according to DSM-5; 3. HAMA=14, HAMD<14; 4. Antianxiety agent should be maitained unchanged at least four weeks pre-treatment and through the study.

Exclusion criteria

Exclusion criteria: With a history of psychiatric disease,such as schizophrenia and bipolar disorder; intracranial organic abnormalities; use of a cardiac pacemaker, or any metal implants;skin lesions; epilepsy; severe cerebral or cardinal or other severe medical disease; alcohol abuser or drugs abuser or pregnant subjects;unsuitable subjects judged by study leader

Design outcomes

Primary

MeasureTime frame
HAMA score;

Contacts

Public ContactYuping Wang

Xuanwu Hospital, Capital Medical University

wangyuping01@sina.cn+86 010-83198273

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026